Disclosures for "Usefulness of Neurofilaments in Serum and Cerebrospinal Fluid as Biomarker for Tunisian Patients with Amyotrophic Lateral Sclerosis"
-
Dr. Kacem has nothing to disclose.
-
Dr. sghaier has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Abida has nothing to disclose.
-
Miss GHARBI has nothing to disclose.
-
Dr. Souissi has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Gouider has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hikma. The institution of Dr. Gouider has received research support from Clinical Investigation Center. The institution of Dr. Gouider has received research support from Menactrims.